1. Home
  2. ICCC vs NVA Comparison

ICCC vs NVA Comparison

Compare ICCC & NVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ICCC
  • NVA
  • Stock Information
  • Founded
  • ICCC 1982
  • NVA 1987
  • Country
  • ICCC United States
  • NVA Australia
  • Employees
  • ICCC N/A
  • NVA N/A
  • Industry
  • ICCC Biotechnology: Pharmaceutical Preparations
  • NVA
  • Sector
  • ICCC Health Care
  • NVA
  • Exchange
  • ICCC Nasdaq
  • NVA NYSE
  • Market Cap
  • ICCC 60.1M
  • NVA 65.4M
  • IPO Year
  • ICCC 1987
  • NVA N/A
  • Fundamental
  • Price
  • ICCC $6.46
  • NVA $12.24
  • Analyst Decision
  • ICCC
  • NVA
  • Analyst Count
  • ICCC 0
  • NVA 0
  • Target Price
  • ICCC N/A
  • NVA N/A
  • AVG Volume (30 Days)
  • ICCC 16.1K
  • NVA 80.8K
  • Earning Date
  • ICCC 08-14-2025
  • NVA 01-01-0001
  • Dividend Yield
  • ICCC N/A
  • NVA N/A
  • EPS Growth
  • ICCC N/A
  • NVA N/A
  • EPS
  • ICCC N/A
  • NVA N/A
  • Revenue
  • ICCC $27,302,766.00
  • NVA N/A
  • Revenue This Year
  • ICCC N/A
  • NVA N/A
  • Revenue Next Year
  • ICCC N/A
  • NVA N/A
  • P/E Ratio
  • ICCC N/A
  • NVA N/A
  • Revenue Growth
  • ICCC 28.29
  • NVA N/A
  • 52 Week Low
  • ICCC $3.34
  • NVA $4.35
  • 52 Week High
  • ICCC $7.60
  • NVA $19.00
  • Technical
  • Relative Strength Index (RSI)
  • ICCC 47.42
  • NVA N/A
  • Support Level
  • ICCC $6.25
  • NVA N/A
  • Resistance Level
  • ICCC $7.30
  • NVA N/A
  • Average True Range (ATR)
  • ICCC 0.34
  • NVA 0.00
  • MACD
  • ICCC -0.03
  • NVA 0.00
  • Stochastic Oscillator
  • ICCC 20.00
  • NVA 0.00

About ICCC ImmuCell Corporation

ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.

About NVA NOVA MINERALS LTD SPON ADS EACH REP 60 ORD

Nova Minerals Ltd is a Gold, Antimony and Critical Minerals exploration and development company focused on advancing the Estelle Project. It includes projects such as Estelle Gold and Critical Minerals Project, RPM, Korbel, Train and Stoney. It operates in one segment which is exploration of minerals and two geographical areas, being Australia and United States, where Australia derives maximum revenue.

Share on Social Networks: